Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP191762.RA0LyjuFSZGo7bwlyDg_GdEDUn_HJnc6rKr0Jp18luf00130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP191762.RA0LyjuFSZGo7bwlyDg_GdEDUn_HJnc6rKr0Jp18luf00130_assertion type Assertion NP191762.RA0LyjuFSZGo7bwlyDg_GdEDUn_HJnc6rKr0Jp18luf00130_head.
- NP191762.RA0LyjuFSZGo7bwlyDg_GdEDUn_HJnc6rKr0Jp18luf00130_assertion description "[In this study, we addressed the hypothesis that transcriptional suppression of erythroblastosis virus E26 oncogene homolog 1 (ETS-1) is an efficient therapeutic approach to pancreatic adenocarcinoma by investigating the effect of ETS-1 suppression in human pancreatic cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP191762.RA0LyjuFSZGo7bwlyDg_GdEDUn_HJnc6rKr0Jp18luf00130_provenance.
- NP191762.RA0LyjuFSZGo7bwlyDg_GdEDUn_HJnc6rKr0Jp18luf00130_assertion evidence source_evidence_literature NP191762.RA0LyjuFSZGo7bwlyDg_GdEDUn_HJnc6rKr0Jp18luf00130_provenance.
- NP191762.RA0LyjuFSZGo7bwlyDg_GdEDUn_HJnc6rKr0Jp18luf00130_assertion SIO_000772 18772901 NP191762.RA0LyjuFSZGo7bwlyDg_GdEDUn_HJnc6rKr0Jp18luf00130_provenance.
- NP191762.RA0LyjuFSZGo7bwlyDg_GdEDUn_HJnc6rKr0Jp18luf00130_assertion wasDerivedFrom befree-20140225 NP191762.RA0LyjuFSZGo7bwlyDg_GdEDUn_HJnc6rKr0Jp18luf00130_provenance.
- NP191762.RA0LyjuFSZGo7bwlyDg_GdEDUn_HJnc6rKr0Jp18luf00130_assertion wasGeneratedBy ECO_0000203 NP191762.RA0LyjuFSZGo7bwlyDg_GdEDUn_HJnc6rKr0Jp18luf00130_provenance.